Despite large variations in p53 expression and reported activity from completely null p53 (Me4405) to gain of oncogenic function (Sk-mel-28) there was no significant differences in repair rates of CPDs across all of the melanoma cell lines. The gene discussed is TP53; the disease is melanoma.